Abstract
Clinical and pharmacological, organizational and legal, forensic and pharmaceutical study of drugs of the N01AX03 group for anesthesia was conducted. A clinical and pharmacological research based on the results of a documentary analysis in a retrospective measurement of indicators of clinical-pharmaceutical safety of ketamine showed that ketamine became the first non-inhalation anesthetic. It causes dissociative anesthesia with an analgesic effect. It is used in emergency surgery, during evacuation in combat conditions, in cardiac surgery, dentistry, ophthalmology, otorhinolaryngology, gynecology. It is prescribed for patients with traumatic shock and blood loss. The organizational and legal research based on the results of the study of the marketing, classification, legal, nomenclature and legal indicators of drugs with ATC code N01AX03 showed the circulation on the pharmaceutical market of Ukraine of 4fourpsychotropic, prescription drugs of ketamine in the form of ampoules and vials for intramuscular and intravenous administration. Forensic and pharmaceutical research based on the results of the study of the control regime, availability, cases from forensic pharmaceutical practice, legal responsibility for the illegal circulation of drugs with ATS code N01AX03 made it possible to establish a direct relationship between the indicated indicators.
Publisher
Shapovalov Scientific Publishing OU (Publications)
Reference53 articles.
1. Shapovalov V. Multidisciplinary study of the level of availability of medicines for cancer patients based on the principles of pharmaceutical law, evidence-based pharmacy, clinical pharmacy, forensic pharmacy, and the organization of a pharmaceutical case. Actual Problems of Medicine and Pharmacy. 2023. Vol.4. No.1. P.1–20. URL: https://doi.org/10.52914/apmp.v4i1.52.
2. Osyntseva A. Cannabinoid addiction: pharmacotherapy, forensic and pharmaceutical practice, availability of drugs. SSP Modern Pharmacy and Medicine. 2023. Vol.3. No.1. P.1-11. URL: https://doi.org/10.53933/sspmpm.v3i1.83.
3. Shapovalova V. Forensic and pharmaceutical risks in the organization of pharmacotherapy of covid, post-covid and long-covid disorders. COVID-19 and vaccination practice standards. SSP Modern Pharmacy and Medicine. 2022. Vol. 2. No. 4. P.1–24. URL: https://doi.org/10.53933/sspmpm.v2i4.69.
4. Shapovalova V.A., Zbrozhek S.I., Shapоvalov V.V. et al. Coronavirus disease pandemia 2019: growth of epidemic dangers. Acta scientific pharmaceutical sciences. 2020. Vol. 4. Iss. 7. P. 61–68. URL: https://www.actascientific.com/ASPS/ASPS-04-0559.php.
5. Shapovalov (Jr.) V., Shapovalova V., Gudzenko A. et al. Organizational and legal analysis of the pharmaceutical provision for the most common diseases of society. International Journal of Pharmaceutical Sciences Review and Research. 2018. Vol.51. N.1. July-August 2018. Article N. 18, P. 118-124. URL: http://globalresearchonline.net/journalcontents/v51-1/18.pdf.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献